Obesity med trial shows disappointing results

(Reuters) UPDATED 2009-03-30

The experimental obesity drug Lorcaserin has shown disappointing results in a recent Phase 3 clinical trial, despite meeting its study goals, experts say. Drugmaker Arena Pharmaceuticals says that the medication did help patients lose weight, but only 10 pounds more than the patients who took a placebo. However, the medication was found to be safe and effective, and its side-effects were similar to those seen with placebo.
Read full story >

See all Diabetes News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Obesity med trial shows disappointing results

People who read this also read...

What the community is saying...

Another Medication for Type 2 Diabetes

Dr. Bill Quick